Last reviewed · How we verify
Blood-stage infection of P. vivax — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Blood-stage infection of P. vivax (Blood-stage infection of P. vivax) — State Key Laboratory of Respiratory Disease.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood-stage infection of P. vivax TARGET | Blood-stage infection of P. vivax | State Key Laboratory of Respiratory Disease | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood-stage infection of P. vivax CI watch — RSS
- Blood-stage infection of P. vivax CI watch — Atom
- Blood-stage infection of P. vivax CI watch — JSON
- Blood-stage infection of P. vivax alone — RSS
Cite this brief
Drug Landscape (2026). Blood-stage infection of P. vivax — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-stage-infection-of-p-vivax. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab